Prostaglandin Analogues – SCCS Final Opinion

Prostaglandin Analogues – SCCS Final Opinion

On 10th of February 2026, the Scientific Committee on Consumer Safety (SCCS) concluded that certain prostaglandin analogues are not considered safe for use in eyebrow and eyelash growth products, based on available research, although non-genotoxic carcinogenicity...
Prostaglandin Analogues – SCCS Final Opinion

Tea Tree Oil – SCCS Final Opinion

SummaryOn 14th of November, the SCCS issued its final opinion confirming Tea Tree Oil as safe for use in shampoos, shower gels, face washes, and face creams when used within the recommended limits. The oil must meet ISO 4730:2017, be restricted to adult-targeted...
Tea tree oil – The HSE’s final opinion

Tea tree oil – The HSE’s final opinion

Substance: Tea Tree Oil The HSE published it’s final opinion on the proposed mandatory classification of Tea Tree Oil which contradicts both the EU RAC’s position. new studies could contribute to changes in hazard identification On August 8, 2025, the Health and...
Prostaglandin Analogues – SCCS Final Opinion

Hydroxyapatite (Nano) –SCCS Final Opinion

Substance: Hydroxyapatite (Nano)Effected Products: Mouthwash and toothpasteDate of Implementation: Not yet adopted, currently at opinion stage On the 4th of July the final opinion on Hydroxyapatite (Submission IV) was submitted by the Scientific Committee on Consumer...
Prostaglandin Analogues – SCCS Final Opinion

EHMC – SCCS Final Opinion

Summary: Substance: Ethylhexyl Methoxycinnamate (EHMC)Effected Products: SunscreenDate of Implementation: Not yet adopted, currently at opinion stage On 30 June 2025, the Scientific Committee on Consumer Safety (SCCS) published its final opinion on the use of UV...